Email
Password
Remember meForgot password?
Log in with Facebook Log in with Twitter
Connect your Digital Journal account with Facebook or Twitter to use this feature.
Connect
Log In Sign Up
In the Media

article imageCounterfeit cancer drug found in the U.S.

article:343423:20::0
By Tim Sandle
Feb 13, 2013 in Health
Share
U.S. authorities have issued a warning about a counterfeit version of a cancer treatment drug called Avastin that has been found in the U.S. The fake version of the drug is connected to a company called Medical Device King.
The warning has been issued by the U.S. Food and Drug Administration (FDA). This warning is the third one that the FDA has issued about counterfeit varieties of Avastin in the past twelve months.
The Wall Street Journal indicates that the latest counterfeit version has been found to have no active ingredient rendering it completely ineffective. The drug has been manufactured for Turkey and is labelled for the Turkish market only. However, supplies have ended up in the U.S.
Even if the drug actually worked, there would be a risk because the Avastin medicine is not licenced for use in the U.S. and has not gone through appropriate trials or tests.
Avastin is sold to treat colon, kidney, brain and lung cancers. An approved form of the drug is manufactured by the pharmaceutical company Roche. According to Fierce Pharma, Roche analyzed three bogus vials of Avastin and found they contained salt, starch, citrate, isopropanol, propanediol, t-butanol, benzoic acid, di-fluorinated benzene ring, acetone and phthalate moiety, but no active ingredients of the cancer drug.
The FDA has advised medics not to use any products from the company Medical Device King. The company has two subsidiary firms called Taranis Medical and Pharmalogical, and the FDA has also cautioned against using products marketed under these brands.
article:343423:20::0
More about Drugs, Pharmaceutical, Cancer, Counterfeit
More news from
Latest News
Top News
Engage

Corporate

Help & Support

News Links

copyright © 2014 digitaljournal.com   |   powered by dell servers